Inobrodib, CAS [[2222941-37-7]]

Produktübersicht

• Artikelname: Inobrodib, CAS [[2222941-37-7]]
• Artikelnummer: MCE-HY-111784
• Hersteller Artikelnummer: HY-111784
• Alternativnummer: MCE-HY-111784-50MG,MCE-HY-111784-10MG,MCE-HY-111784-100MG,MCE-HY-111784-10MMX1ML,MCE-HY-111784-25MG,MCE-HY-111784-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: CCS1477

Produktbeschreibung

Inobrodib (CCS1477) is an orally active, potent, and selective inhibitor of the p300/CBP bromodomain. Inobrodib binds to p300 and CBP with Kd values of 1.3 and 1.7 nM, respectively, and with 170/130-fold selectivity compared with BRD4 with a Kd of 222 nM. CCS1477 inhibits cell proliferation in prostate cancer cell lines and decreases androgen receptor (AR)- and C-MYC-regulated gene expression[1].

Produkteigenschaften

• Molekulargewicht: 534.60
• Reinheit: 99.95
• CAS Nummer: [2222941-37-7]
• Formel: C30H32F2N4O3
• Target-Kategorie: Epigenetic Reader Domain

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound